Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000428 | DNA-directed RNA polymerase complex | 4 | 4 |
GO:0030880 | RNA polymerase complex | 3 | 4 |
GO:0032991 | protein-containing complex | 1 | 4 |
GO:0061695 | transferase complex, transferring phosphorus-containing groups | 4 | 4 |
GO:0140535 | intracellular protein-containing complex | 2 | 4 |
GO:1902494 | catalytic complex | 2 | 4 |
GO:1990234 | transferase complex | 3 | 4 |
GO:0005736 | RNA polymerase I complex | 4 | 1 |
GO:0055029 | nuclear DNA-directed RNA polymerase complex | 3 | 1 |
GO:0140513 | nuclear protein-containing complex | 2 | 1 |
Related structures:
AlphaFold database: A0A3Q8IHM6
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 7 |
GO:0006351 | DNA-templated transcription | 7 | 6 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 7 |
GO:0006807 | nitrogen compound metabolic process | 2 | 7 |
GO:0008152 | metabolic process | 1 | 7 |
GO:0009058 | biosynthetic process | 2 | 7 |
GO:0009059 | macromolecule biosynthetic process | 4 | 7 |
GO:0009987 | cellular process | 1 | 7 |
GO:0016070 | RNA metabolic process | 5 | 7 |
GO:0018130 | heterocycle biosynthetic process | 4 | 7 |
GO:0019438 | aromatic compound biosynthetic process | 4 | 7 |
GO:0032774 | RNA biosynthetic process | 5 | 7 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 7 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 4 | 7 |
GO:0043170 | macromolecule metabolic process | 3 | 7 |
GO:0044237 | cellular metabolic process | 2 | 7 |
GO:0044238 | primary metabolic process | 2 | 7 |
GO:0044249 | cellular biosynthetic process | 3 | 7 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 7 |
GO:0046483 | heterocycle metabolic process | 3 | 7 |
GO:0071704 | organic substance metabolic process | 2 | 7 |
GO:0090304 | nucleic acid metabolic process | 4 | 7 |
GO:0097659 | nucleic acid-templated transcription | 6 | 6 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 7 |
GO:1901362 | organic cyclic compound biosynthetic process | 4 | 7 |
GO:1901576 | organic substance biosynthetic process | 3 | 7 |
GO:0006353 | DNA-templated transcription termination | 6 | 1 |
GO:0006363 | termination of RNA polymerase I transcription | 7 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 7 |
GO:0005488 | binding | 1 | 7 |
GO:0008270 | zinc ion binding | 6 | 7 |
GO:0043167 | ion binding | 2 | 7 |
GO:0043169 | cation binding | 3 | 7 |
GO:0046872 | metal ion binding | 4 | 7 |
GO:0046914 | transition metal ion binding | 5 | 7 |
GO:0097159 | organic cyclic compound binding | 2 | 7 |
GO:1901363 | heterocyclic compound binding | 2 | 7 |
GO:0003677 | DNA binding | 4 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 202 | 206 | PF00656 | 0.639 |
CLV_NRD_NRD_1 | 141 | 143 | PF00675 | 0.598 |
CLV_NRD_NRD_1 | 45 | 47 | PF00675 | 0.425 |
CLV_PCSK_KEX2_1 | 141 | 143 | PF00082 | 0.646 |
CLV_PCSK_KEX2_1 | 45 | 47 | PF00082 | 0.425 |
CLV_PCSK_SKI1_1 | 167 | 171 | PF00082 | 0.517 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.461 |
DEG_SPOP_SBC_1 | 147 | 151 | PF00917 | 0.628 |
DOC_CKS1_1 | 75 | 80 | PF01111 | 0.596 |
DOC_CYCLIN_yCln2_LP_2 | 33 | 39 | PF00134 | 0.417 |
DOC_MAPK_RevD_3 | 31 | 46 | PF00069 | 0.423 |
DOC_PP2B_LxvP_1 | 33 | 36 | PF13499 | 0.425 |
DOC_PP4_FxxP_1 | 19 | 22 | PF00568 | 0.481 |
DOC_USP7_MATH_1 | 23 | 27 | PF00917 | 0.467 |
DOC_USP7_UBL2_3 | 148 | 152 | PF12436 | 0.592 |
DOC_WW_Pin1_4 | 181 | 186 | PF00397 | 0.551 |
DOC_WW_Pin1_4 | 25 | 30 | PF00397 | 0.537 |
DOC_WW_Pin1_4 | 7 | 12 | PF00397 | 0.459 |
DOC_WW_Pin1_4 | 74 | 79 | PF00397 | 0.653 |
LIG_14-3-3_CanoR_1 | 141 | 147 | PF00244 | 0.570 |
LIG_14-3-3_CanoR_1 | 177 | 181 | PF00244 | 0.651 |
LIG_14-3-3_CanoR_1 | 221 | 227 | PF00244 | 0.319 |
LIG_14-3-3_CanoR_1 | 61 | 67 | PF00244 | 0.459 |
LIG_BRCT_BRCA1_1 | 27 | 31 | PF00533 | 0.458 |
LIG_CSL_BTD_1 | 20 | 23 | PF09270 | 0.463 |
LIG_EVH1_1 | 21 | 25 | PF00568 | 0.457 |
LIG_FHA_1 | 103 | 109 | PF00498 | 0.451 |
LIG_FHA_1 | 168 | 174 | PF00498 | 0.474 |
LIG_FHA_1 | 214 | 220 | PF00498 | 0.282 |
LIG_FHA_1 | 30 | 36 | PF00498 | 0.431 |
LIG_FHA_2 | 121 | 127 | PF00498 | 0.436 |
LIG_FHA_2 | 163 | 169 | PF00498 | 0.465 |
LIG_FHA_2 | 200 | 206 | PF00498 | 0.655 |
LIG_LIR_Nem_3 | 3 | 9 | PF02991 | 0.458 |
LIG_Pex14_2 | 27 | 31 | PF04695 | 0.458 |
LIG_REV1ctd_RIR_1 | 161 | 171 | PF16727 | 0.539 |
LIG_SH2_STAT3 | 175 | 178 | PF00017 | 0.495 |
LIG_SH2_STAT5 | 175 | 178 | PF00017 | 0.532 |
LIG_SH2_STAT5 | 41 | 44 | PF00017 | 0.429 |
LIG_SH2_STAT5 | 86 | 89 | PF00017 | 0.494 |
LIG_SH3_2 | 11 | 16 | PF14604 | 0.457 |
LIG_SH3_3 | 19 | 25 | PF00018 | 0.474 |
LIG_SH3_3 | 216 | 222 | PF00018 | 0.288 |
LIG_SH3_3 | 8 | 14 | PF00018 | 0.568 |
LIG_Sin3_3 | 55 | 62 | PF02671 | 0.456 |
LIG_WRC_WIRS_1 | 24 | 29 | PF05994 | 0.460 |
LIG_WW_2 | 22 | 25 | PF00397 | 0.464 |
MOD_CDK_SPxxK_3 | 9 | 16 | PF00069 | 0.448 |
MOD_CK1_1 | 155 | 161 | PF00069 | 0.566 |
MOD_CK1_1 | 67 | 73 | PF00069 | 0.665 |
MOD_CK1_1 | 93 | 99 | PF00069 | 0.590 |
MOD_CK2_1 | 120 | 126 | PF00069 | 0.536 |
MOD_CK2_1 | 162 | 168 | PF00069 | 0.472 |
MOD_CK2_1 | 229 | 235 | PF00069 | 0.288 |
MOD_GlcNHglycan | 130 | 133 | PF01048 | 0.541 |
MOD_GlcNHglycan | 157 | 161 | PF01048 | 0.613 |
MOD_GlcNHglycan | 197 | 200 | PF01048 | 0.565 |
MOD_GlcNHglycan | 231 | 234 | PF01048 | 0.310 |
MOD_GlcNHglycan | 66 | 69 | PF01048 | 0.640 |
MOD_GSK3_1 | 148 | 155 | PF00069 | 0.648 |
MOD_GSK3_1 | 176 | 183 | PF00069 | 0.662 |
MOD_GSK3_1 | 195 | 202 | PF00069 | 0.595 |
MOD_GSK3_1 | 23 | 30 | PF00069 | 0.500 |
MOD_GSK3_1 | 241 | 248 | PF00069 | 0.310 |
MOD_GSK3_1 | 60 | 67 | PF00069 | 0.469 |
MOD_N-GLC_2 | 111 | 113 | PF02516 | 0.457 |
MOD_NEK2_1 | 156 | 161 | PF00069 | 0.555 |
MOD_NEK2_1 | 180 | 185 | PF00069 | 0.674 |
MOD_NEK2_1 | 213 | 218 | PF00069 | 0.282 |
MOD_NEK2_1 | 241 | 246 | PF00069 | 0.304 |
MOD_NEK2_2 | 120 | 125 | PF00069 | 0.506 |
MOD_OFUCOSY | 113 | 118 | PF10250 | 0.433 |
MOD_PKA_1 | 141 | 147 | PF00069 | 0.530 |
MOD_PKA_2 | 114 | 120 | PF00069 | 0.459 |
MOD_PKA_2 | 140 | 146 | PF00069 | 0.631 |
MOD_PKA_2 | 176 | 182 | PF00069 | 0.567 |
MOD_PKA_2 | 227 | 233 | PF00069 | 0.310 |
MOD_PKA_2 | 60 | 66 | PF00069 | 0.454 |
MOD_Plk_4 | 235 | 241 | PF00069 | 0.310 |
MOD_ProDKin_1 | 181 | 187 | PF00069 | 0.555 |
MOD_ProDKin_1 | 25 | 31 | PF00069 | 0.539 |
MOD_ProDKin_1 | 7 | 13 | PF00069 | 0.458 |
MOD_ProDKin_1 | 74 | 80 | PF00069 | 0.648 |
TRG_DiLeu_BaLyEn_6 | 47 | 52 | PF01217 | 0.429 |
TRG_ER_diArg_1 | 140 | 142 | PF00400 | 0.592 |
TRG_ER_diArg_1 | 45 | 47 | PF00400 | 0.412 |
TRG_Pf-PMV_PEXEL_1 | 207 | 211 | PF00026 | 0.459 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P3H9 | Leptomonas seymouri | 64% | 100% |
A4HPT3 | Leishmania braziliensis | 77% | 100% |
A4IE59 | Leishmania infantum | 100% | 100% |
E9ATJ8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |
Q4Q100 | Leishmania major | 89% | 100% |